HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elizabeth A Lawson Selected Research

Weight Loss (Weight Reduction)

7/2021The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans.
1/2021Oxytocin Administration Increases Proactive Control in Men with Overweight or Obesity: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
1/2020The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis.
1/2019Radcliffe ARFID Workgroup: Toward operationalization of research diagnostic criteria and directions for the field.
1/2018Effects of Intranasal Oxytocin on the Blood Oxygenation Level-Dependent Signal in Food Motivation and Cognitive Control Pathways in Overweight and Obese Men.
12/2017The effects of oxytocin on eating behaviour and metabolism in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elizabeth A Lawson Research Topics

Disease

26Anorexia Nervosa
01/2021 - 06/2007
12Obesity
07/2021 - 02/2011
8Body Weight (Weight, Body)
11/2022 - 08/2007
8Overweight
01/2021 - 02/2011
7Feeding and Eating Disorders (Eating Disorder)
01/2020 - 06/2007
6Weight Loss (Weight Reduction)
07/2021 - 12/2017
5Weight Gain
07/2021 - 08/2006
4Avoidant Restrictive Food Intake Disorder
11/2022 - 01/2019
4Mental Disorders (Mental Disorder)
01/2020 - 11/2013
4Metabolic Bone Diseases (Osteopenia)
11/2012 - 12/2009
2Hypopituitarism (Sheehan's Syndrome)
08/2021 - 01/2021
2Inflammation (Inflammations)
07/2021 - 08/2007
2Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
01/2021 - 01/2019
2Body Dysmorphic Disorders (Body Dysmorphic Disorder)
01/2020 - 01/2019
2Malnutrition (Nutritional Deficiencies)
01/2019 - 08/2007
2Insulin Resistance
12/2017 - 05/2015
2Neoplasms (Cancer)
11/2017 - 07/2009
1Septo-Optic Dysplasia
01/2022
1Craniopharyngioma (Craniopharyngiomas)
01/2022
1Cysts
01/2022
1Prader-Willi Syndrome (Syndrome, Prader-Willi)
01/2022
1Glioma (Gliomas)
01/2022
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
01/2022
1Hyperphagia (Overeating)
07/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2021
1Body Weight Changes
01/2021
1Diabetes Insipidus
01/2019
1Diabetes Mellitus
12/2017
1Pheochromocytoma
11/2017
1Primary Hyperparathyroidism
11/2017
1Paraganglioma (Paragangliomas)
11/2017
1Bulimia (Binge Eating)
01/2015
1Osteoporosis
03/2013
1Social Phobia
11/2012
1Hyponatremia
11/2012
1Anorexia
10/2012
1Amenorrhea
02/2011
1Prolactinoma (Prolactinomas)
01/2010
1Parkinson Disease (Parkinson's Disease)
01/2010
1Hyperprolactinemia
01/2010
1Islet Cell Adenoma (Islet Cell Tumors)
07/2009
1Hemangiopericytoma
07/2009
1Hypoglycemia (Reactive Hypoglycemia)
07/2009
1Euthyroid Sick Syndromes (Euthyroid Sick Syndrome)
07/2008
1Hypogonadism (Hypergonadotropic Hypogonadism)
07/2008
1Cardiovascular Diseases (Cardiovascular Disease)
08/2007

Drug/Important Bio-Agent (IBA)

25Oxytocin (Pitocin)FDA LinkGeneric
08/2021 - 11/2011
10Hormones (Hormone)IBA
11/2022 - 02/2010
5GhrelinIBA
01/2021 - 08/2014
5LeptinIBA
01/2020 - 11/2011
3Neurotransmitter Agents (Neurotransmitter)IBA
01/2021 - 11/2017
3Peptides (Polypeptides)IBA
01/2021 - 01/2020
3Peptide YYIBA
01/2020 - 07/2008
3Testosterone (Sustanon)FDA Link
10/2019 - 06/2007
3AN 12IBA
04/2016 - 02/2011
3Hydrocortisone (Cortisol)FDA LinkGeneric
09/2015 - 12/2009
2Vasopressins (Vasopressin)IBA
01/2021 - 01/2019
27,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
01/2020 - 01/2019
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2020 - 01/2015
2Estrogens (Estrogen)FDA Link
10/2019 - 08/2007
2CarbohydratesIBA
08/2019 - 05/2015
2Proteins (Proteins, Gene)FDA Link
08/2019 - 07/2009
2Insulin-Like Growth Factor I (IGF-1)IBA
11/2010 - 08/2007
2Oral ContraceptivesIBA
08/2007 - 08/2006
1Cholecystokinin (Pancreozymin)IBA
11/2022
1pyroglutamyl-histidyl-glycineIBA
01/2021
1Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1VitaminsIBA
08/2019
1SugarsIBA
08/2019
1relamorelinIBA
01/2018
1NeuropeptidesIBA
01/2018
11- (diethylaminopropyl)- 4- phenylpiperazineIBA
11/2017
1Parathyroid Hormone (Parathormone)IBA
11/2017
1Myc associated factor XIBA
11/2017
1Oxytocin Receptors (Oxytocin Receptor)IBA
01/2017
1pivalyloxymethyl butyrateIBA
08/2014
1Adrenocorticotropic Hormone (ACTH)FDA Link
11/2013
1SodiumIBA
11/2012
1Diphosphonates (Bisphosphonates)IBA
07/2011
1Risedronic Acid (Actonel)FDA LinkGeneric
07/2011
1Human Growth Hormone (Saizen)FDA LinkGeneric
11/2010
1Islet Amyloid PolypeptideIBA
03/2010
1Dopamine Agonists (Dopamine Agonist)IBA
01/2010
1CabergolineFDA LinkGeneric
01/2010
1Messenger RNA (mRNA)IBA
07/2009
1Insulin-Like Growth Factor II (Somatomedin A)IBA
07/2009
1Growth Hormone (Somatotropin)IBA
07/2008
1Dietary Fats (Dietary Fat)IBA
08/2007
1Interleukin-6 (Interleukin 6)IBA
08/2007
1C-Reactive ProteinIBA
08/2007
1AndrogensIBA
06/2007

Therapy/Procedure

6Therapeutics
07/2021 - 06/2007
1Diet Therapy (Therapy, Diet)
11/2022
1Colonic Pouches (S Pouch)
01/2022
1Enteral Nutrition (Feeding, Tube)
01/2019